# A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer)

> clinical trial · VERIFIED · 2026-08-18

Status: RECRUITING · Sponsor: Latin American Cooperative Oncology Group · Condition: Lung Cancer

- Company: Latin American Cooperative Oncology Group
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06822543

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.